JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5251
Bank7 Corp
BSVN
$528M
| $15K | ﹤0.01% |
837
-196
| -19% | -$3.08K |
2018 Q4
1 quarter
|
|
5252
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17B
| $15K | ﹤0.01% |
356
-543
| -60% | -$22.4K |
2017 Q1
8 quarters
|
|
5253
WisdomTree US LargeCap Fund
EPS
$1.66B
| $15K | ﹤0.01% |
477
+238
| +100% | +$7.32K |
2018 Q4
1 quarter
|
|
5254
Fortress Biotech
FBIO
$67.7M
| $15K | ﹤0.01% |
569
-199
| -26% | -$5.22K |
2017 Q4
5 quarters
|
|
5255
Coffee Holding Co
JVA
$22.7M
| $15K | ﹤0.01% |
2,835
+2,735
| +2,735% | +$15.8K |
2018 Q4
1 quarter
|
|
5256
Kodiak Sciences
KOD
$5.94B
| $15K | ﹤0.01% |
2,315
-544
| -19% | -$4.02K |
2018 Q4
1 quarter
|
|
5257
Medallion Financial
MFIN
$273M
| $15K | ﹤0.01% |
+2,200
| New | +$12.9K |
2019 Q1
0 quarters
|
|
5258
PrimeEnergy Resources
PNRG
$324M
| $15K | ﹤0.01% |
+92
| New | +$11.7K |
2019 Q1
0 quarters
|
|
5259
Invesco Bloomberg Pricing Power ETF
POWA
$166M
| $15K | ﹤0.01% |
+307
| New | +$14.7K |
2019 Q1
0 quarters
|
|
5260
Invesco Large Cap Value ETF
PWV
$1.8B
| $15K | ﹤0.01% |
+419
| New | +$14.8K |
2019 Q1
0 quarters
|
|
5261
Invesco S&P 500 Revenue ETF
RWL
$9.72B
| $15K | ﹤0.01% |
290
+145
| +100% | +$7.33K |
2018 Q4
1 quarter
|
|
5262
Sibanye-Stillwater
SBSW
$7.05B
| $15K | ﹤0.01% |
3,690
-521,319
| -99% | -$1.97M |
2013 Q2
23 quarters
|
|
5263
Cambria Shareholder Yield ETF
SYLD
$964M
| $15K | ﹤0.01% |
+405
| New | +$14.5K |
2019 Q1
0 quarters
|
|
|
XXII
5264
PUT
22nd Century Group
XXII
$653K
| – | – |
0
| – | – |
2019 Q1
0 quarters
|
|
5265
Astrana Health
ASTH
$1.78B
| $15K | ﹤0.01% |
811
-39
| -5% | -$748 |
2018 Q2
3 quarters
|
|
|
MGI
5266
DELISTED
MoneyGram International, Inc. New
MGI
| $15K | ﹤0.01% |
7,533
-355
| -5% | -$810 |
2014 Q2
19 quarters
|
|
|
NWHM
5267
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $15K | ﹤0.01% |
3,159
-327
| -9% | -$1.96K |
2017 Q4
5 quarters
|
|
|
DZSI
5268
DELISTED
DZS Inc. Common Stock
DZSI
| $15K | ﹤0.01% |
1,443
-16,204
| -92% | -$205K |
2016 Q4
9 quarters
|
|
|
MBTF
5269
DELISTED
MBT Financial Corporation
MBTF
| $15K | ﹤0.01% |
1,492
-4,002
| -73% | -$41.9K |
2016 Q1
12 quarters
|
|
5270
PUT
Allogene Therapeutics
ALLO
$518M
| $14K | ﹤0.01% |
+500
| New | +$14.5K |
2019 Q1
0 quarters
|
|
5271
Fennec Pharmaceuticals
FENC
$358M
| $14K | ﹤0.01% |
2,831
-802
| -22% | -$5.27K |
2018 Q2
3 quarters
|
|
5272
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.85B
| $14K | ﹤0.01% |
270
| – | – |
2016 Q1
12 quarters
|
|
5273
Pan American Silver
PAAS
$18.9B
| $14K | ﹤0.01% |
1,109
-78,227
| -99% | -$1.1M |
2014 Q1
20 quarters
|
|
5274
CALL
Pacific Biosciences
PACB
$790M
| $14K | ﹤0.01% |
2,000
-239,200
| -99% | -$1.73M |
2018 Q4
1 quarter
|
|
5275
Invesco Golden Dragon China ETF
PGJ
$82M
| $14K | ﹤0.01% |
345
-164
| -32% | -$6.1K |
2015 Q4
13 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.